PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Andrea C Tricco¹, Erin Lillie², Wasifa Zarin², Kelly K O'Brien³, Heather Colquhoun³, Danielle Levac⁴, David Moher⁵, Micah D J Peters⁶, Tanya Horsley⁷, Laura Weeks⁸, Susanne Hempel⁹, Elie A Akl¹⁰, Christine Chang¹¹, Jessie McGowan¹², Lesley Stewart¹³, Lisa Hartling¹⁴, Adrian Aldcroft¹⁵, Michael G Wilson¹⁶, Chantelle Garritty⁵, Simon Lewin¹⁷, Christina M Godfrey¹⁸, Marilyn T Macdonald¹⁹, Etienne V Langlois²⁰, Karla Soares-Weiser²¹, Jo Moriarty²², Tammy Clifford⁸, Özge Tunçalp²⁰, Sharon E Straus¹

Affiliations

¹ St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada (A.C.T., S.E.S.).
² St. Michael's Hospital, Toronto, Ontario, Canada (E.L., W.Z.).
³ University of Toronto, Toronto, Ontario, Canada (K.K.O., H.C.).
⁴ Northeastern University, Boston, Massachusetts (D.L.).
⁵ Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (D.M., C.G.).
⁶ University of South Australia and University of Adelaide, Adelaide, South Australia, Australia (M.D.P.).
⁷ Royal College of Physicians and Surgeons of Canada, Ottawa, Ontario, Canada (T.H.).
⁸ Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada (L.W., T.C.).
⁹ RAND Corporation, Santa Monica, California (S.H.).
¹⁰ American University of Beirut, Beirut, Lebanon (E.A.A.).
¹¹ Agency for Healthcare Research and Quality, Rockville, Maryland (C.C.).
¹² University of Ottawa, Ottawa, Ontario, Canada (J.M.).
¹³ University of York, York, United Kingdom (L.S.).
¹⁴ University of Alberta, Edmonton, Alberta, Canada (L.H.).
¹⁵ BMJ Open, London, United Kingdom (A.A.).
¹⁶ McMaster University, Hamilton, Ontario, Canada (M.G.W.).
¹⁷ Norwegian Institute of Public Health, Oslo, Norway, and South African Medical Research Council, Cape Town, South Africa (S.L.).
¹⁸ Queen's University, Kingston, Ontario, Canada (C.M.G.).
¹⁹ Dalhousie University, Halifax, Nova Scotia, Canada (M.T.M.).
²⁰ World Health Organization, Geneva, Switzerland (E.V.L., Ö.T.).
²¹ Cochrane, London, United Kingdom (K.S.).
²² King's College London, London, United Kingdom (J.M.).

PMID: 30178033
DOI: 10.7326/M18-0850

Free article

Guideline

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Andrea C Tricco et al. Ann Intern Med. 2018.

Free article

. 2018 Oct 2;169(7):467-473.

doi: 10.7326/M18-0850. Epub 2018 Sep 4.

Authors

Affiliations

¹ St. Michael's Hospital and University of Toronto, Toronto, Ontario, Canada (A.C.T., S.E.S.).
² St. Michael's Hospital, Toronto, Ontario, Canada (E.L., W.Z.).
³ University of Toronto, Toronto, Ontario, Canada (K.K.O., H.C.).
⁴ Northeastern University, Boston, Massachusetts (D.L.).
⁵ Ottawa Hospital Research Institute, Ottawa, Ontario, Canada (D.M., C.G.).
⁶ University of South Australia and University of Adelaide, Adelaide, South Australia, Australia (M.D.P.).
⁷ Royal College of Physicians and Surgeons of Canada, Ottawa, Ontario, Canada (T.H.).
⁸ Canadian Agency for Drugs and Technologies in Health, Ottawa, Ontario, Canada (L.W., T.C.).
⁹ RAND Corporation, Santa Monica, California (S.H.).
¹⁰ American University of Beirut, Beirut, Lebanon (E.A.A.).
¹¹ Agency for Healthcare Research and Quality, Rockville, Maryland (C.C.).
¹² University of Ottawa, Ottawa, Ontario, Canada (J.M.).
¹³ University of York, York, United Kingdom (L.S.).
¹⁴ University of Alberta, Edmonton, Alberta, Canada (L.H.).
¹⁵ BMJ Open, London, United Kingdom (A.A.).
¹⁶ McMaster University, Hamilton, Ontario, Canada (M.G.W.).
¹⁷ Norwegian Institute of Public Health, Oslo, Norway, and South African Medical Research Council, Cape Town, South Africa (S.L.).
¹⁸ Queen's University, Kingston, Ontario, Canada (C.M.G.).
¹⁹ Dalhousie University, Halifax, Nova Scotia, Canada (M.T.M.).
²⁰ World Health Organization, Geneva, Switzerland (E.V.L., Ö.T.).
²¹ Cochrane, London, United Kingdom (K.S.).
²² King's College London, London, United Kingdom (J.M.).

PMID: 30178033
DOI: 10.7326/M18-0850

Abstract

Scoping reviews, a type of knowledge synthesis, follow a systematic approach to map evidence on a topic and identify main concepts, theories, sources, and knowledge gaps. Although more scoping reviews are being done, their methodological and reporting quality need improvement. This document presents the PRISMA-ScR (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) checklist and explanation. The checklist was developed by a 24-member expert panel and 2 research leads following published guidance from the EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network. The final checklist contains 20 essential reporting items and 2 optional items. The authors provide a rationale and an example of good reporting for each item. The intent of the PRISMA-ScR is to help readers (including researchers, publishers, commissioners, policymakers, health care providers, guideline developers, and patients or consumers) develop a greater understanding of relevant terminology, core concepts, and key items to report for scoping reviews.

PubMed Disclaimer

Comment in

Scoping Reviews and Systematic Reviews: Is It an Either/Or Question?
Chang S. Chang S. Ann Intern Med. 2018 Oct 2;169(7):502-503. doi: 10.7326/M18-2205. Epub 2018 Sep 4. Ann Intern Med. 2018. PMID: 30178036 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Affiliations

PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation

Authors

Affiliations

Abstract

Comment in

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources